FMP
Enter
API Tools
Extras
Loncar China BioPharma ETF
CHNA
NASDAQ
Inactive Equity
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
13.53 USD
-0.0095 (-0.07021%)
Valuation Date:
Oct 17, 2023 3:51 PM
Share Price on Valuation Date
$13.53
Stock Beta
0.92
Shares Outstanding
0
